NCT00220103View on ClinicalTrials.gov

Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2002

Conditions
Adenocarcinoma of Oesophagus
Interventions
DRUG

epirubicin, capecitabine, cisplatin

PROCEDURE

Surgical resection

Trial Locations (1)

Unknown

Royal Marsden NHS Foundation Trust, Sutton

All Listed Sponsors
lead

Royal Marsden NHS Foundation Trust

OTHER

NCT00220103 - Pre-operative Epirubicin, Cisplatin, and Capecitabine in Patients With Newly Diagnosed Localised Oesophageal Adenocarcinoma | Biotech Hunter | Biotech Hunter